UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000043825
Receipt No. R000050020
Scientific Title Safety evaluation of an excessive consumption of food material - Randomized, double-blind, placebo-controlled parallel group study -
Date of disclosure of the study information 2021/04/02
Last modified on 2021/04/02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Safety evaluation of an excessive consumption of food material
- Randomized, double-blind, placebo-controlled parallel group study -
Acronym Safety evaluation of an excessive consumption of food material
Scientific Title Safety evaluation of an excessive consumption of food material
- Randomized, double-blind, placebo-controlled parallel group study -
Scientific Title:Acronym Safety evaluation of an excessive consumption of food material
Region
Japan

Condition
Condition Not applicable
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the safety of excessive consumption of food material for 4
weeks
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Expression rate of side effect, Expression rate of Adverse event , clinical examination items, physiological examination items
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Test food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks.
Interventions/Control_2 Control food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1)Males and females equal to or more than 20 years and less than 65 years of age
2)Subjects who visit on schedule days
3)Subjects who recognize the object and contents of the study and submit the written informed consent
Key exclusion criteria 1)Subjects who BMI >=30.0 kg/m2 or <18.5 kg/m2
2)Subjects who have systolic blood pressure <90 mmHg
3)Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study
4)Subjects who have a history of severe illness and current medical history in the heart, liver, kidney, digestive organs
5)Subjects who regularly use drugs, health foods, and supplements
6)Females in pregnancy, lactation and scheduled pregnancy during test period.
7)Heavy alcoholic beverager(40g alcohol/day>=), heavy smoker(21 cigarettes/day>=)
8)Subjects who feel bad mood by blood collection in past
9)Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period
10)Night shift worker
11)Don't usually have breakfast
12)Subjects who plan business trip or trip for 10 days or more a month
13)Subjects who have allergy related to the study foods
14)Those who have been diagnosed with chronic constipation
15)Dysphagic person
16)Subjects already participating in other clinical trials
17)Subjects who are ineligible due to physician's judgement
Target sample size 50

Research contact person
Name of lead principal investigator
1st name Ikuo
Middle name
Last name Fukuhara
Organization Fukuhara Clinic
Division name Hospital director
Zip code 061-1351
Address 3-1-15 Shimamatsuhigashi-machi, Eniwa, Hokkaido, Japan
TEL 0123-36-8029
Email i-feniwa@gray.plala.or.jp

Public contact
Name of contact person
1st name Toyotada
Middle name
Last name Ashino
Organization New drug research center, Inc.
Division name Clinical Research Dept.
Zip code 061-1405
Address 452-1 Toiso, Eniwa-shi, Hokkaido, Japan
TEL 0123-34-0412
Homepage URL
Email t-ashino@ndrcenter.co.jp

Sponsor
Institute Maruzen Pharmaceuticals Co., Ltd
Institute
Department

Funding Source
Organization Maruzen Pharmaceuticals Co., Ltd
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Fukuhara Clinic Clinical Trial Review Committee
Address 1-15, Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido
Tel 0123-36-8029
Email d-kameda@mediffom.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 04 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 03 Month 24 Day
Date of IRB
2021 Year 03 Month 22 Day
Anticipated trial start date
2021 Year 04 Month 26 Day
Last follow-up date
2021 Year 06 Month 23 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 04 Month 02 Day
Last modified on
2021 Year 04 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050020

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.